Safe Effective Healthcare
Natural Medicine

Vitamin B3 beats Merck’s Zetia cholesterol drug

The utter worthlessness of Big Pharma’s cholesterol drugs was demonstrated recently by a study published in the New England Journal of Medicine which showed that niacin (a low-cost B vitamin) out-performs Merck’s drug Zetia for preventing the build-up of arterial plaque, a symptom of cardiovascular disease.

As the study reveals, Zetia failed miserably. Patients taking niacin showed a “significant shrinkage” in artery wall thickness, while those on Zetia showed no such improvement. At the same time, the rate of “cardiovascular events” in the niacin group was only one-fifth that in the Zetia group, demonstrating that niacin is far more effective at preventing heart attacks and other similar events than Zetia.

But curiously, as soon as niacin started to show a real benefit over Zetia, researchers cancelled the study. The premature ending of the clinical trial stopped the process by which even more useful information about the benefits of niacin might have been learned.

5,800% higher price than niacin

Merck, the maker of Zetia, was likely horrified to learn that a low-cost B vitamin out-performed its blockbuster drug. Sales of its Zetia drug are reportedly over $5 billion. It’s no wonder: Zetia sells for as much as $3.89 per pill.

Niacin, on the other hand, costs as little as 6.7 cents per pill, even in a “no-flush” time-release formula from a quality source like the NSI brand from Vitacost: http://www.vitacost.com/NSI-No-Flus…

These price differences make Zetia 5,800% more expensive than niacin. And yet niacin works better.

So if niacin works better, and if modern medicine claims to be serving patients instead of profits, why don’t doctors recommend B vitamins instead of expensive cholesterol drugs?

The next time you visit your doctor to get your chlesterol prescription renewed, perhaps you should ask him or her.

Comments are closed.